ResMed Inc
(OTCPK:RSMDF)
$
16.72
(0%)
Market Cap: 31.68 Bil
Enterprise Value: 29.59 Bil
PE Ratio: 20.22
PB Ratio: 4.68
GF Score: 94/100 Resmed Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2020 / 10:00PM GMT
Release Date Price:
$17.6
Gretel Janu;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
All right. Hi, everyone. So my name is Gretel Janu. So I've got here, Mick Farrell, CEO of ResMed; and Dave Pendarvis, CAO of ResMed.
So Mick, David, thank you very much for your time today for joining our conference. Now it's great to have you here virtually.
Questions & Answers
Gretel Janu;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
So I think to start us off, Mick, do you want to start off to give us an update as to how the business has performed during COVID? A quick highlight of the latest results, given they were just a couple of weeks ago, and then we'll jump into some of the questions.
Michael J. Farrell
ResMed Inc. - CEO & Director
Yes. Sounds good, Gretel. I'll do just a very brief maybe 3-minute intro, and then allow the bulk of the time, Gretel, for you to facilitate Q&A from the team that's on.
So look, incredible 2020 here with
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot